Pharmacokinetics and Pharmacodynamics of High Dose Methotrexate in Children with Acute Lymphoblastic Leukemia and down Syndrome: a Case Cohort Study

被引：0
|
作者：
Buitenkamp, T. [1 ]
Mathot, R. [2 ]
Vulto, A. [2 ]
Veerman, A. [3 ]
van Wering, E. [4 ]
Pieters, R. [1 ]
Van Den Heuvel, M. [1 ]
Zwaan, Christian M. [1 ]
机构：
[1] Erasmus MC, Dept Pediat Hem Onc, Rotterdam, Netherlands
[2] Erasmus MC, Dept Pharm, Rotterdam, Netherlands
[3] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[4] Dutch Childhood Oncol Grp, The Hague, Netherlands
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：574 / 575
页数：2
相关论文
共 50 条
  • [1] Myelotoxicity Following High-Dose Methotrexate in Children with Down Syndrome and Acute Lymphoblastic Leukemia
    Bohnstedt, C.
    Levinsen, M.
    Rosthoj, S.
    Zeller, B.
    Taskinen, M.
    Hafsteinsdottir, S.
    Bjorgvinsdottir, H.
    Heymann, M.
    Schmiegelow, K.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S104 - S104
  • [2] Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukemia
    Yang, L.-H. (yang_lihua@sina.com), 2005, Chinese Medical Association (40)
  • [3] High dose methotrexate in the treatment of children with acute lymphoblastic leukemia
    Lukito, Johannes Bondan
    PAEDIATRICA INDONESIANA, 2007, 47 (01) : 1 - 6
  • [4] Pharmacokinetics of High-Dose Methotrexate in Infants Treated for Acute Lymphoblastic Leukemia
    Lonnerholm, Gudmar
    Valsecchi, Maria Grazia
    De Lorenzo, Paola
    Schrappe, Martin
    Hovi, Liisa
    Campbell, Myriam
    Mann, Georg
    Janka-Schaub, Gritta
    Li, Chi-Kong
    Stary, Jan
    Hann, Ian
    Pieters, Rob
    PEDIATRIC BLOOD & CANCER, 2009, 52 (05) : 596 - 601
  • [5] Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia
    Buitenkamp, Trudy D.
    Mathot, Ron A. A.
    de Haas, Valerie
    Pieters, Rob
    Zwaan, C. Michel
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1106 - 1113
  • [6] Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia
    Csordas, Katalin
    Hegyi, Marta
    Eipel, Oliver T.
    Muller, Judit
    Erdelyi, Daniel J.
    Kovacs, Gabor T.
    ANTI-CANCER DRUGS, 2013, 24 (02) : 189 - 197
  • [7] High-dose methotrexate for the treatment of acute lymphoblastic leukemia in children (a pharmacokinetic study)
    Slany, J
    Grundmann, M
    Brozmanova, H
    Blazek, B
    Sterba, J
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA II, 1997, 3 : 183 - 188
  • [8] Toxicity associated with high dose methotrexate in children with acute lymphoblastic leukemia
    Sinha, Rupal
    Bansal, Shweta
    Abedin, Sarfraz
    Kapoor, Gauri
    PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 526 - 526
  • [9] Understanding the Associations between High-Dose Methotrexate Pharmacokinetics and the Risk of Adverse Events in Children and Adolescents with Down Syndrome Associated High-Risk Acute Lymphoblastic Leukemia
    Westmoreland, Kate D.
    Taylor, Zachary L.
    Miller, Tamara P.
    Chavana, Ashley
    Rabin, Karen R.
    Brown, Austin L.
    Bernhardt, Melanie Brooke
    Schafer, Eric S.
    O'Brien, Maureen M.
    Castellino, Sharon M.
    Ramsey, Laura B.
    BLOOD, 2024, 144 : 1438 - 1439
  • [10] Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia
    Aumente, Dolores
    Buelga, Dolores Santos
    Lukas, John C.
    Gomez, Pedro
    Torres, Antonio
    Garcia, Maria Jose
    CLINICAL PHARMACOKINETICS, 2006, 45 (12) : 1227 - 1238
12345